Related Guides
Continue your research with these related independent reviews.
TMates vs Embody 2026
Two compounded GLP-1 telehealth programs with different pricing philosophies. Same-price-all-doses month-to-month vs flat refill pricing — and the data on which one converts better.
At a Glance
TMates
Best OverallBest for shoppers committing 6+ months. Same price across all doses. Multi-vertical: also offers NAD+, TRT, ED, hair loss.
- Semaglutide $158–$249/mo (12-mo plan = lowest)
- Tirzepatide $167–$297/mo (12-mo plan = lowest)
- Same price all doses (no titration upcharge)
- Injectable + oral formats
- 2,400+ patients, free shipping, cancel anytime
Embody
Best for First MonthBest for patients who want flat refill pricing and a needle-free GLP-1 gum option. No long-term commitment required.
- $149 first month (Spring Forward $200 off)
- Flat $299/mo refills (no escalation fees)
- GLP-1 Gum (oral chewable tirzepatide) — unique
- HSA/FSA eligible
- Pause anytime
The Full Side-by-Side
Every claim in this table is sourced to either a live brand-site crawl (May 6, 2026) or our Katalys partner dashboard. No estimates.
| Dimension | TMates | Embody |
|---|---|---|
| Compounded Semaglutide — entry price | $249/mo (1-month plan, any dose) | $149 first month, then $299/mo flat |
| Compounded Semaglutide — 12-month price | $158/mo ($1,900 paid upfront, save 37%) | $299/mo (no long-term discount) |
| Compounded Tirzepatide — entry price | $297/mo (1-month plan) | $299/mo flat (after $149 first month) |
| Compounded Tirzepatide — 12-month price | $167/mo ($1,999 upfront, save 44%) | $299/mo flat (no long-term discount) |
| Dose-escalation upcharge? | No — same price all doses | No — flat $299/mo refills |
| Available formats | Injectable + Oral (drops) | Injectable + GLP-1 Gum (chewable) |
| Plan length flexibility | 1, 3, 6, or 12 months | Monthly subscription only |
| Other treatments offered | NAD+, TRT, ED, Skin, Hair Loss | GLP-1 only (focused) |
| Active promo (May 2026) | No standalone promo — discount built into longer plans | Spring Forward: $200 off first month + free expedited shipping |
| Cancellation | Cancel anytime | Pause anytime |
| HSA/FSA eligible | Verify on tmates.com | Yes (eligible) |
| Customer base size | 2,400+ patients | Not publicly disclosed |
| Realized EPC (Katalys May 2026) | $16.09 — #1 highest in our entire Katalys account | $4.72 |
| Realized conversion rate (Katalys May 2026) | 6.43% | 1.38% |
Pricing Deep Dive
TMates Tiered Plans
TMates uses commitment-based discounts: the longer you commit upfront, the lower your effective monthly price. All dosages are the same price within a plan.
- 1 month — $249
- 3 months — $650 ($217/mo, save 13%)
- 6 months — $1,050 ($175/mo, save 30%)
- 12 months — $1,900 ($158/mo, save 37%)
- 1 month — $297
- 3 months — $800 ($267/mo, save 10%)
- 6 months — $1,299 ($217/mo, save 27%)
- 12 months — $1,999 ($167/mo, save 44%)
Embody Flat Pricing
Embody uses simple two-tier pricing: discounted first month, then flat refills regardless of dose escalation. No long-term commitment required.
- First month — $149 (with Spring Forward $200 off)
- All refills — $299/mo flat
- GLP-1 Gum (chewable tirz) — verify on joinem.co
12-Month Cost Comparison
If you commit to a full year of compounded semaglutide:
- TMates 12-month plan: $1,900 total ($158/mo)
- Embody monthly: $149 + ($299 × 11) = $3,438 total ($286/mo average)
- Difference: $1,538 saved on TMates over 12 months
Trade-off: TMates requires the full $1,900 upfront. Embody is $149 to start with no long-term commitment.
Format Options: Injection, Oral, or Gum
Both providers go beyond standard injectable GLP-1, but in different directions:
TMates: Injectable + Oral Drops
TMates offers the same medication (semaglutide or tirzepatide) in both injectable and oral drop formats at the same price. Patients can switch between formats month-to-month. The oral drop format is taken sublingually (under the tongue).
Best for: Patients with mild-to-moderate needle aversion who still want a familiar drop-format alternative; patients who want the option to switch formats.
Embody: Injectable + GLP-1 Gum
Embody is the only verified provider in our stack offering compounded tirzepatide in a chewable gum format. The gum is a daily oral alternative to weekly injections — meant for patients with strong needle aversion.
Best for: Patients with severe needle aversion who want a needle-free GLP-1 option, even if absorption efficiency may differ from injectable.
Who Should Pick Which?
Pick TMates if:
- You're committed to compounded GLP-1 long-term and can pay $1,900 upfront for the 12-month plan ($158/mo average — among the lowest verified rates).
- You want oral drop format alongside injectable at the same price.
- You want one provider for GLP-1 + NAD+, TRT, ED, or hair loss (multi-vertical).
- You're titrating up and want to avoid dose-escalation upcharges.
- You value being on the highest-converting funnel in the verified stack (6.43% CR — Katalys data).
Pick Embody if:
- You want the lowest first-month entry price ($149 with Spring Forward $200 off).
- You don't want to commit to a multi-month plan upfront.
- You have severe needle aversion and want to try the GLP-1 gum format.
- You want predictable flat $299/mo refill pricing without dose-escalation surprises.
- HSA/FSA eligibility is important to you (Embody confirms; TMates verify).
Our Verdict
For most shoppers, TMates is our top pick — the 12-month plan delivers $158/mo semaglutide and $167/mo tirzepatide (among the lowest verified GLP-1 prices in our entire stack), the same-price-all-doses pricing eliminates titration upcharges, and the multi-vertical menu (NAD+, TRT, ED, hair) means one provider for several conditions.
Embody wins on first-month entry and needle-free options. The $149 first-month price with Spring Forward is the lowest entry in our verified stack, the GLP-1 gum is a genuinely unique format for needle-averse patients, and the flat $299 refill pricing is honest and simple.
The data also tells a story: TMates' 6.43% conversion rate vs Embody's 1.38% (Katalys May 2026) suggests TMates' transparent tiered-pricing funnel converts better than Embody's promo-driven first-month hook. Real customer behavior is voting with checkout completions.
FAQ
Which is cheaper for compounded semaglutide, TMates or Embody?
It depends on commitment length. Embody costs $149 the first month (with the Spring Forward $200-off promo) and then $299/month flat for refills. TMates starts at $249 for a single month but drops to $158/month on a 12-month plan. Crossover: month-to-month is cheaper at Embody ($299 vs $249); 6-month is roughly equivalent ($299 vs $175); 12-month is dramatically cheaper at TMates ($158 vs $299 — a $1,692/year difference).
Does TMates or Embody have a needle-free GLP-1?
Both. TMates offers oral semaglutide and oral tirzepatide (alongside injectables) at the same price as the injectable — a unique value proposition. Embody offers a GLP-1 chewing gum format (oral chewable tirzepatide), which is unique to Embody and the only gum-format GLP-1 in our verified Katalys stack. Patients with strong needle aversion may prefer the gum format; patients wanting traditional oral drops should look at TMates.
Which has better customer conversion data, TMates or Embody?
TMates has the higher EPC ($16.09 vs $4.72) and higher conversion rate (6.43% vs 1.38%) in our Katalys partner data as of May 2026. Both are real, paying customer programs — these are not estimates. The gap suggests TMates has a more compelling intake-to-purchase funnel (likely driven by transparent same-price-all-doses pricing and the visible 1/3/6/12-month plan structure).
Are TMates and Embody both compounded or branded?
Both are compounded-only telehealth providers. Neither carries branded Wegovy, Zepbound, Mounjaro, or Ozempic. Compounded semaglutide and tirzepatide are produced by 503A or 503B compounding pharmacies and are typically 60-90% cheaper than branded equivalents. Patients who specifically want FDA-approved branded GLP-1 should look at Eden Health, Ivim Health, or Ro instead.
Does TMates or Embody charge dose-escalation fees?
Neither. Both providers charge a flat price regardless of dose. TMates explicitly markets "Same Price All Doses" across semaglutide (0.25mg–2.4mg) and tirzepatide (2.5mg–15mg). Embody uses a flat $299/month refill price after the first month. This is a meaningful differentiator vs providers that charge more as patients titrate up — a common GLP-1 compounded-telehealth pricing gotcha.
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.